Buy Semaglutide in Boston — $99/Month | Trimi Health
GLP-1 weight loss treatment in Boston — shipped directly to your Boston address in 2–3 business days. No clinic visits, no insurance required, just $99/month for compounded semaglutide.
More on GLP-1 by Location
Why Boston Residents Choose Telehealth for GLP-1
Boston is a major metropolitan area with a population of approximately ~680,000 city / ~4.9 million metro. Despite access to quality healthcare facilities, affordable GLP-1 weight loss medications remain out of reach for many Boston residents. Local weight loss clinics typically charge $400–700 per month for compounded semaglutide programs, and brand-name Wegovy costs $1,000–$1,400 per month without insurance.
With an adult obesity rate of approximately 25%, Boston faces significant public health challenges related to weight management. Many neighborhoods lack convenient access to specialized weight loss clinics, making telehealth an increasingly popular alternative for Boston residents seeking GLP-1 treatment.
Boston GLP-1 Snapshot
Population: ~680,000 city / ~4.9 million metro. Adult obesity rate: ~25%. Typical clinic cost: $400–700/mo. Brand Wegovy: $1,000–$1,400/mo. Trimi telehealth: $99/mo semaglutide, $125/mo tirzepatide.
Learn more about how telehealth prescribing works. You can also read about Ozempic vs. Wegovy or explore our GLP-1 beginner guide.
Boston Pricing: Trimi vs Local Providers & Pharmacies
| Option | Monthly Cost | In-Person Visit | Insurance Required |
|---|---|---|---|
| Boston Weight Loss Clinic (avg) | $400–700 | Yes | Sometimes |
| Boston Pharmacy (brand Wegovy) | $1,000–$1,400 | Yes | Recommended |
| Trimi Telehealth (compounded) | $99/mo (sema) / $125/mo (tirz) | No | No |
Read our semaglutide vs. tirzepatide comparison to understand which medication may be right for you.
How It Works: 3 Steps to Get Semaglutide in Boston
Step 1: Online Health Intake
Complete a health questionnaire covering your medical history, medications, BMI, and weight loss goals — from anywhere in Boston.
Step 2: Provider Review & Prescription
A licensed provider evaluates your submission, confirms GLP-1 candidacy, and sends your prescription to a licensed compounding pharmacy.
Step 3: Delivered to Your Boston Door
Temperature-controlled packaging arrives at your Boston address within 3–5 business days. Monthly refills ship automatically.
Check our GLP-1 candidacy guide to see if you qualify.
Available Medications for Boston Residents
Compounded Semaglutide
$99/month
- Same active ingredient as Wegovy
- Weekly self-injection
- ~15% average weight loss at 68 weeks
- No insurance required
Compounded Tirzepatide
$125/month
- Dual GLP-1/GIP receptor agonist
- Weekly self-injection
- ~22% average weight loss at 72 weeks
- No insurance required
Learn about compounded medication safety and explore our GLP-1 weight loss timeline to set realistic expectations.
Getting Started with Trimi in Boston
Boston residents with a BMI of 27+ (with a weight-related condition) or 30+ may qualify for GLP-1 treatment through Trimi. Whether you're in South Boston, Jamaica Plain, or Newton or anywhere in the greater Boston area, medication ships directly to your door.
Explore our first month on semaglutide guide, learn about managing GLP-1 side effects, or see diet tips while on semaglutide.
Ready to Start in Boston?
Get compounded semaglutide delivered to any Boston address for $99/month. No office visit, no insurance, no waiting room.
Get Started for $99/MonthFrequently Asked Questions: Semaglutide in Boston
Can I get semaglutide in Boston without visiting a clinic?
Yes. Trimi offers compounded semaglutide entirely through telehealth. Boston residents complete an online health intake, receive a provider evaluation, and get medication shipped directly to their Boston address — no in-person visit required.
How much does semaglutide cost at Boston weight loss clinics?
Boston-area weight loss clinics in neighborhoods like Back Bay, Brookline, and Cambridge typically charge $400–700 per month for compounded semaglutide programs. Trimi delivers the same compounded semaglutide for $99/month.
How fast is shipping to Boston?
Most Boston residents receive their compounded semaglutide within 3–5 business days after prescription approval. Medication ships directly to your Boston address — whether you're in South Boston, Jamaica Plain, or Newton.
Is telehealth prescribing legal in Massachusetts?
Yes. Massachusetts law permits licensed providers to conduct telehealth evaluations and prescribe medications including GLP-1 agonists. Trimi connects Boston residents with licensed providers who manage care entirely online.
Does Trimi offer tirzepatide as well as semaglutide in Boston?
Yes. Trimi offers both compounded semaglutide at $99/month and compounded tirzepatide at $125/month for Boston residents. A licensed provider will help determine which medication best fits your health goals.
What makes Boston a high-need market for GLP-1 medications?
Boston has an adult obesity rate of approximately 25%, and many residents face barriers to affordable weight management. Telehealth GLP-1 programs like Trimi fill a critical gap by delivering medication directly to Boston addresses at a fraction of clinic prices.
Can I continue treatment if I move within the Boston area?
Yes. Because Trimi is a telehealth program, your care is tied to your account — not a clinic location. Whether you move within Boston or to a nearby suburb like Quincy or Wellesley, your treatment continues without interruption.
Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. Semaglutide and tirzepatide are prescription medications requiring evaluation by a licensed healthcare provider. Individual results vary. Common side effects include nausea, vomiting, diarrhea, and constipation. Not appropriate for individuals with a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome.
Sources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- Suffolk County Public Health Department. Community Health Assessment 2023.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).